Achilles has proven accomplishments in every dimension of health care, is internationally recognized for his academic achievements, technology transfer accomplishments, clinical program growth and development,” said Thomas F. Zenty III, CEO of UH.
Cleveland, Ohio (PRWEB) August 08, 2012
Achilles A. Demetriou, MD, PhD, FACS, has announced that he will be retiring from full time employment at the Northeast Ohio health system, University Hospitals, effective Dec. 31, 2012.
Dr. Demetriou joined University Hospitals in 2005 and has been credited with leading numerous initiatives gaining the health system national recognition for quality outcomes, operating efficiencies, financial performance, strategic positioning and system integration. Most recently, Dr. Demetriou was a leader in the launch of The Harrington Project for Discovery and Development, a first-of-its-kind $250 million initiative to advance early stage drug discovery in academic medicine to commercialization.
"It has been a privilege to work for a 150-year-old historic organization such as University Hospitals for the last seven years of my professional life," said Dr. Demetriou. "It is incredibly rewarding to be in an environment that is leading the discoveries of tomorrow and at the same time dedicated to its employees and committed to its communities. I wish my colleagues and the health system continued success and will remain in the Cleveland area which clearly is unsurpassed in the fields of biotechnology, research and medicine.”
Dr. Demetriou has nearly four decades of professional commitment to patient care, research and teaching. He has been a successful leader in many internationally and nationally recognized hospitals and health systems including Albert Einstein College of Medicine, Vanderbilt University Medical Center, and Cedars-Sinai Medical Center.
During his career, Dr. Demetriou distinguished himself internationally for his research and clinical work in liver disease and has published over 400 papers, and given 190 lectures and presentations at universities and scientific meetings around the world. He is recognized as a pioneer in the development of the bioartificial liver, a device that extends the lives of patients whose livers have failed. He performed extensive research in liver cell transplantation and the role of defective genes in the development of cirrhosis and other liver abnormalities. His most recent research has focused on the impact of novel robotic and non-invasive surgical technologies in the clinical setting.
Dr. Demetriou holds a medical degree from Hebrew University-Hadassah Medical School in Jerusalem, Israel. After graduating from medical school, he accepted a research fellowship at the Biochemical Pharmacology Laboratory of the National Institute of Arthritis, Metabolism and Digestive Diseases; earned his doctorate in biochemistry from George Washington University, and completed a surgical residency at Vanderbilt University Medical Center and Affiliated Hospitals.
Dr. Demetriou has also been an active business leader during his tenure at University Hospitals and served on numerous boards including, BioEnterprise and is currently chairman of the board at BioMotiv. He also serves as Professor of Surgery and Vice Dean for Clinical Affairs at Case Western Reserve University School of Medicine and is a member of numerous surgical and other specialty societies and serves on several editorial and scientific advisory boards.
“Achilles has proven accomplishments in every dimension of health care, is internationally recognized for his academic achievements, technology transfer accomplishments, clinical program growth and development,” said Thomas F. Zenty III, Chief Executive Officer, University Hospitals. “On behalf of our entire health system and the communities that we serve, we sincerely appreciate Achilles’ outstanding service to patients worldwide and his leadership and many achievements at University Hospitals.”
University Hospitals will immediately begin a nation wide search to evaluate physician executives to fill the health system’s role of chief operating officer.
"It is our goal to ensure a smooth transition and we are fortunate to have an exceptional medical and administrative leadership team in place while we complete our search at the end of this year,” added Mr. Zenty.
- * * *
About University Hospitals
University Hospitals serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians. At the core of our health system is University Hospitals Case Medical Center. The primary affiliate of Case Western Reserve University School of Medicine, University Hospitals Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. University Hospitals Case Medical Center is the 2012 recipient of the American Hospital Association – McKesson Quest for Quality Prize for its leadership and innovation in quality improvement and safety.
For more information, go to http://www.uhhospitals.org